NFAT2 mediates high glucose-induced glomerular podocyte apoptosis through increased Bax expression-Reference-Cited by-同舟云学术

NFAT2 mediates high glucose-induced glomerular podocyte apoptosis through increased Bax expression

Published:2013-04 Issue:7 Volume:319 Page:992-1000
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Li Ruizhao,Zhang Li,Shi Wei,Zhang Bin,Liang Xinling,Liu Shuangxin,Wang Wenjian

Publisher

Elsevier BV

Subject

Cell Biology

Reference37 articles.

1. United States renal data system 2011 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States;Collins;Am. J. Kidney Dis.,2012

2. Clinical practice. Nephropathy in patients with type 2 diabetes;Remuzzi;N. Engl. J. Med.,2002

3. Evolving strategies for renoprotection: diabetic nephropathy;Parving;Curr. Opin. Nephrol. Hypertens.,2001

4. Reno-protective effects of renin–angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis;Vejakama;Diabetologia,2012

5. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy;Wolf;Diabetes,2005

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B virus-targeting sodium taurocholate cotransporting polypeptide mediates HBV infection and damage in human renal podocytes;Microbiology Spectrum;2024-03-05

2. Li, P HY-021068 alleviates cerebral ischemia-reperfusion injury by inhibiting NLRP1 inflammasome and restoring autophagy function in mice;Experimental Neurology;2024-01

3. Inhibition of the lncRNA 585189 prevents podocyte injury and mitochondria dysfunction by promoting hnRNP A1 and SIRT1 in diabetic nephropathy;Molecular and Cellular Endocrinology;2023-12

4. Cellular crosstalk of mesangial cells and tubular epithelial cells in diabetic kidney disease;Cell Communication and Signaling;2023-10-16

5. How does NFAT3 regulate the occurrence of cardiac hypertrophy?;IJC Heart & Vasculature;2023-10